{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Otherwise+Healthy+Overweight+or+Obese", "query": { "condition": "Otherwise Healthy Overweight or Obese" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 14, "total_pages": 2, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Otherwise+Healthy+Overweight+or+Obese&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-06-26T07:12:55.526Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05963594", "title": "To Evaluate the Post-Prandial Metabolic Effects of Oligomalt in Adults With T2D and in HAO", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Dietary Supplement" ], "interventions": [ { "name": "Oligomalt", "type": "DIETARY_SUPPLEMENT" }, { "name": "maltodextrin", "type": "DIETARY_SUPPLEMENT" } ], "intervention_types": [ "DIETARY_SUPPLEMENT" ], "sponsor": "Société des Produits Nestlé (SPN)", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 44, "start_date": "2023-01-23", "completion_date": "2023-03-28", "has_results": false, "last_update_posted_date": "2023-07-27", "last_synced_at": "2026-06-26T07:12:55.526Z", "location_count": 1, "location_summary": "Tustin, California", "locations": [ { "city": "Tustin", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05963594" }, { "nct_id": "NCT03775278", "title": "A Study of Safety, Tolerability, and Pharmacokinetics of Multiple-Ascending Doses of PHP-303 in Otherwise Healthy Overweight or Obese Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Otherwise Healthy Overweight or Obese" ], "interventions": [ { "name": "PHP-303", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "pH Pharma", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 50, "start_date": "2018-12-17", "completion_date": "2020-04-07", "has_results": false, "last_update_posted_date": "2020-04-13", "last_synced_at": "2026-06-26T07:12:55.526Z", "location_count": 1, "location_summary": "Overland Park, Kansas", "locations": [ { "city": "Overland Park", "state": "Kansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03775278" }, { "nct_id": "NCT07340125", "title": "Pistachio Snacking and Metabolic Flexibility", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Overweight (BMI > 25)", "Obese But Otherwise Healthy Participants", "Overweight or Obese", "Obese Patients (BMI ≥ 30 kg/m²)", "Poor Sleep Quality", "Healthy Participants", "Physically Inactive" ], "interventions": [ { "name": "Pistachio", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of South Carolina", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "25 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "25 Years to 45 Years" }, "enrollment_count": 60, "start_date": "2025-09-01", "completion_date": "2026-12-31", "has_results": false, "last_update_posted_date": "2026-01-14", "last_synced_at": "2026-06-26T07:12:55.526Z", "location_count": 1, "location_summary": "Columbia, South Carolina", "locations": [ { "city": "Columbia", "state": "South Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT07340125" }, { "nct_id": "NCT04839393", "title": "A Drug-Drug Interaction Study Between PF-06882961 and PF-06865571 in Healthy Adult Participants and Overweight Adults or Adults With Obesity Who Are Otherwise Healthy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Volunteer" ], "interventions": [ { "name": "PF-06882961 followed by PF-06882961/PF-06865571", "type": "DRUG" }, { "name": "PF-06882961/PF-06865571 followed by PF-06882961", "type": "DRUG" }, { "name": "PF-06882961 + PF-06865571", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 27, "start_date": "2021-04-05", "completion_date": "2021-11-08", "has_results": true, "last_update_posted_date": "2023-08-21", "last_synced_at": "2026-06-26T07:12:55.526Z", "location_count": 1, "location_summary": "Tustin, California", "locations": [ { "city": "Tustin", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04839393" }, { "nct_id": "NCT07224399", "title": "Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BGM1812 Injection Following Single and Multiple Subcutaneous Administration in Normal to Overweight or Obese But Otherwise Healthy Men and Women", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healhty", "Overweight or Obesity" ], "interventions": [ { "name": "BGM1812", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "BrightGene Bio-Medical Technology Co., Ltd.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 60, "start_date": "2025-10-09", "completion_date": "2026-05-15", "has_results": false, "last_update_posted_date": "2025-11-06", "last_synced_at": "2026-06-26T07:12:55.526Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT07224399" }, { "nct_id": "NCT06567327", "title": "A Study to Learn How the Study Medicine Danuglipron is Taken Up Into the Blood and If Danuglipron Changes How the Body Processes Other Study Medicines (Atorvastatin and Rosuvastatin) in Healthy Adults Who Are Overweight or Obese", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Obesity" ], "interventions": [ { "name": "Danuglipron", "type": "DRUG" }, { "name": "Atorvastatin", "type": "DRUG" }, { "name": "Rosuvastatin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "64 Years", "sex": "ALL", "summary": "18 Years to 64 Years" }, "enrollment_count": 82, "start_date": "2024-08-28", "completion_date": "2025-04-14", "has_results": false, "last_update_posted_date": "2025-08-06", "last_synced_at": "2026-06-26T07:12:55.526Z", "location_count": 3, "location_summary": "Anaheim, California • South Miami, Florida", "locations": [ { "city": "Anaheim", "state": "California" }, { "city": "South Miami", "state": "Florida" }, { "city": "South Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT06567327" }, { "nct_id": "NCT06857617", "title": "This Study Will Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of MET097 in Adult Participants With Overweight or Obesity", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Obesity and Overweight" ], "interventions": [ { "name": "(Part C) MET097", "type": "BIOLOGICAL" }, { "name": "(Part C) Placebo", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Metsera, a wholly owned subsidiary of Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 120, "start_date": "2024-04-01", "completion_date": "2025-03-15", "has_results": false, "last_update_posted_date": "2026-01-28", "last_synced_at": "2026-06-26T07:12:55.526Z", "location_count": 3, "location_summary": "Anaheim, California • Cypress, California • Overland Park, Kansas", "locations": [ { "city": "Anaheim", "state": "California" }, { "city": "Cypress", "state": "California" }, { "city": "Overland Park", "state": "Kansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT06857617" }, { "nct_id": "NCT06440980", "title": "A Study to Compare Tablets and Capsules of Orforglipron (LY3502970) in Healthy Participants Who Are Obese or Overweight", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy", "Obese", "Overweight", "Obesity" ], "interventions": [ { "name": "Orforglipron", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 533, "start_date": "2024-06-24", "completion_date": "2025-06-02", "has_results": false, "last_update_posted_date": "2025-06-24", "last_synced_at": "2026-06-26T07:12:55.526Z", "location_count": 7, "location_summary": "Anaheim, California • Los Alamitos, California • Daytona Beach, Florida + 4 more", "locations": [ { "city": "Anaheim", "state": "California" }, { "city": "Los Alamitos", "state": "California" }, { "city": "Daytona Beach", "state": "Florida" }, { "city": "Overland Park", "state": "Kansas" }, { "city": "Springfield", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT06440980" }, { "nct_id": "NCT07022977", "title": "A Study of MET233 in Individuals With Obesity or Overweight", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Obesity and Overweight" ], "interventions": [ { "name": "MET233", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 144, "start_date": "2024-11-06", "completion_date": "2026-04-21", "has_results": false, "last_update_posted_date": "2026-05-26", "last_synced_at": "2026-06-26T07:12:55.526Z", "location_count": 1, "location_summary": "Cypress, California", "locations": [ { "city": "Cypress", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07022977" }, { "nct_id": "NCT06568731", "title": "A Study to Learn How Different Amounts of the Study Medicine Danuglipron Are Taken up Into the Blood in Otherwise Healthy Adults With Overweight or Obesity", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Obesity" ], "interventions": [ { "name": "Danuglipron", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 23, "start_date": "2024-08-23", "completion_date": "2024-12-18", "has_results": false, "last_update_posted_date": "2025-01-20", "last_synced_at": "2026-06-26T07:12:55.526Z", "location_count": 1, "location_summary": "New Haven, Connecticut", "locations": [ { "city": "New Haven", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT06568731" } ] }